Quantification of 2'-deoxy-2'-β-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies.
2'-Deoxy-2'-β-fluoro-4'-azidocytidine (FNC) is a novel pyrimidine analog that inhibits not only the replication of the hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV but also the replication of lamivudine-resistant HBV, 4'-azidocytidine or 2'-β-methylcytidine-resistant HCV, and nucleoside reverse-transcriptase inhibitor-resistant HIV variants. The present study was undertaken to evaluate the absolute oral bioavailability of FNC in rats and the pharmacokinetic properties of FNC after intragastric administration of single and multiple doses in rats and dogs. A sensitive high-performance liquid chromatography tandem quadrupole time-of-flight mass spectrometry (HPLC/Q-TOF MS) method and a reliable high-performance liquid chromatography tandem triple quadrupole mass spectrometry (HPLC/QqQ MS/MS) method were established for the determination of FNC in the rat and dog plasmas, respectively. The sample preparation involved a protein-precipitation method with methanol after the addition of lamivudine as an internal standard. FNC was analyzed by LC using a YMC-Pack Pro C18 column (150mm×4.6mm, 3μm) with methanol (containing 0.3% formic acid): 10mM ammonium acetate (containing 0.3% formic acid, pH 2.8) (35:65, v/v) as the mobile phase. Both mass spectrometers were equipped with an electrospray ionization interface in the positive-ion mode. The linear range was from 2.00 to 2000.00ngmL(-1) in rat plasma and 0.50 to 400.00ngmL(-1) in dog plasma. The intraday and interday precision were less than 10.55%, and the accuracy was in the range of -5.86 to 5.13%. The mean recoveries were greater than 82.70% and 82.97% for FNC and IS, respectively. The HPLC/Q-TOF MS and HPLC/QqQ MS/MS methods were both successfully applied in the pharmacokinetic studies of FNC in rats and dogs.
['Peng|Youmei|Y|', 'Cheng|Tiefeng|T|', 'Dong|Lihong|L|', 'Zhang|Yuhai|Y|', 'Chen|Xiaojing|X|', 'Jiang|Jinhua|J|', 'Zhang|Jingmin|J|', 'Guo|Xiaohe|X|', 'Guo|Mintong|M|', 'Chang|Junbiao|J|', 'Wang|Qingduan|Q|']
D000818:Animals D001682:Biological Availability D002851:Chromatography, High Pressure Liquid D003562:Cytidine D003841:Deoxycytidine D004285:Dogs D005260:Female D019259:Lamivudine D008297:Male D013058:Mass Spectrometry D010949:Plasma D051381:Rats D017207:Rats, Sprague-Dawley D012015:Reference Standards
Bioavailability Pharmacokinetics 2′-Deoxy-2′-β-fluoro-4′-azidocytidine High-performance liquid chromatography-quadrupole time-of-flight mass spectrometry High-performance liquid chromatography-triple quadrupole mass spectrometry